Cancer BiologyCancersPeer-reviewed
Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma
Bih‐Rong Wei, Vincenzo Verdi, Shuling Zhang…·Richard J. Simpson
This study identifies a compensatory cyclin D2 response as a mechanism conferring trametinib resistance in canine mucosal melanoma.
DOI 10.3390/cancers17142357